• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞动脉炎修订分类标准的评估及其临床表型。

Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes.

机构信息

Rheumatology, Department of Clinical Sciences, Lund University, Malmö, UK.

Rheumatology, Department of Clinical Sciences, Lund University, Lund, Sweden, UK.

出版信息

Rheumatology (Oxford). 2021 Dec 24;61(1):383-387. doi: 10.1093/rheumatology/keab353.

DOI:10.1093/rheumatology/keab353
PMID:33871583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8742823/
Abstract

BACKGROUND

GCA is a systemic vasculitis of the elderly, viewed by many as a disease with multiple and overlapping clinical phenotypes. Retrospective studies have shown differences in clinical presentation between these phenotypes. To reflect the heterogeneity of GCA and novel diagnostic methods, new classification criteria have been proposed.

METHODS

This is a retrospective study of newly diagnosed patients with GCA at the outpatient rheumatology clinics at Skåne University Hospital (Malmö and Lund) between 2012 and 2018. All patients were evaluated using two sets of classification criteria, the ACR classification criteria from 1990 and a proposed revision of these criteria requiring objective findings (positive biopsy or imaging) for classification. Patients were further classified as one of four widely used clinical phenotypes.

RESULTS

A total of 183 patients with a new diagnosis of GCA were identified. The diagnosis was confirmed by one or two experienced rheumatologists in 116 of these patients during a review of medical records. The ACR criteria were more sensitive than the revised criteria (93.1% vs 72.4%), but the revised criteria had higher specificity (94.0% vs 28.4%). The revised criteria tended to have higher sensitivity in the phenotype with constitutional symptoms compared with cranial GCA (P = 0.08).

CONCLUSION

The specificity of the ACR classification criteria for GCA can be improved by using revised criteria requiring objective findings of vasculitis. In addition, the wider symptoms covered by the revised criteria may improve classification of patients with a phenotype characterized by constitutional symptoms.

摘要

背景

GCA 是一种老年系统性血管炎,许多人认为它是一种具有多种重叠临床表型的疾病。回顾性研究表明,这些表型之间的临床表现存在差异。为了反映 GCA 的异质性和新的诊断方法,已经提出了新的分类标准。

方法

这是一项在 2012 年至 2018 年间在斯科讷大学医院(马尔默和隆德)的门诊风湿病诊所新诊断为 GCA 的患者的回顾性研究。所有患者均使用两套分类标准进行评估,一套是 1990 年的 ACR 分类标准,另一套是需要客观发现(阳性活检或影像学)才能分类的标准修订版。患者进一步分为四种广泛使用的临床表型之一。

结果

共确定了 183 例新诊断为 GCA 的患者。在对这些患者中的 116 名患者的病历进行审查期间,由一到两名经验丰富的风湿病学家确诊。ACR 标准比修订后的标准更敏感(93.1%比 72.4%),但修订后的标准特异性更高(94.0%比 28.4%)。修订后的标准在有全身症状的表型中与颅 GCA 相比,具有更高的敏感性(P=0.08)。

结论

通过使用需要血管炎客观发现的修订标准,可以提高 ACR 分类标准对 GCA 的特异性。此外,修订后的标准涵盖的更广泛的症状可能会改善以全身症状为特征的患者的分类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/333d/8742823/fb0d2b7d6458/keab353f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/333d/8742823/fb0d2b7d6458/keab353f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/333d/8742823/fb0d2b7d6458/keab353f1.jpg

相似文献

1
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes.巨细胞动脉炎修订分类标准的评估及其临床表型。
Rheumatology (Oxford). 2021 Dec 24;61(1):383-387. doi: 10.1093/rheumatology/keab353.
2
Performance of the new 2022 ACR/EULAR classification criteria for giant cell arteritis in clinical practice in relation to its clinical phenotypes.2022年美国风湿病学会/欧洲抗风湿病联盟巨细胞动脉炎新分类标准在临床实践中与其临床表型相关的表现。
Autoimmun Rev. 2023 Oct;22(10):103413. doi: 10.1016/j.autrev.2023.103413. Epub 2023 Aug 19.
3
Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care.2022 年 ACR/EULAR 巨细胞动脉炎分类标准在常规临床护理中诊断疑似巨细胞动脉炎患者的性能。
RMD Open. 2023 Apr;9(2). doi: 10.1136/rmdopen-2022-002970.
4
Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria.巨细胞动脉炎的血管炎分布及临床特征:一项采用2022年美国风湿病学会/欧洲抗风湿病联盟新分类标准的回顾性研究
Front Med (Lausanne). 2023 Nov 13;10:1286601. doi: 10.3389/fmed.2023.1286601. eCollection 2023.
5
External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic.荷兰快速通道诊所中疑似巨细胞动脉炎患者中 2022 年 ACR/EULAR 分类标准的外部验证。
RMD Open. 2023 Jul;9(3). doi: 10.1136/rmdopen-2023-003080.
6
Classification/diagnostic criteria for GCA/PMR.巨细胞动脉炎/多发性肌炎的分类/诊断标准。
Clin Exp Rheumatol. 2000 Jul-Aug;18(4 Suppl 20):S4-5.
7
Is temporal artery biopsy essential in all cases of suspected giant cell arteritis?颞动脉活检对于所有疑似巨细胞动脉炎的病例都是必不可少的吗?
Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-84-9. Epub 2015 May 26.
8
Large-vessel giant cell arteritis: a cohort study.巨细胞动脉炎(大动脉炎):一项队列研究。
Rheumatology (Oxford). 2015 Mar;54(3):463-70. doi: 10.1093/rheumatology/keu329. Epub 2014 Sep 5.
9
Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.验证 2022 年美国风湿病学会/欧洲抗风湿病联盟 Takayasu 动脉炎分类标准。
Rheumatology (Oxford). 2023 Oct 3;62(10):3427-3432. doi: 10.1093/rheumatology/kead161.
10
Temporal artery biopsy for suspected giant cell arteritis: a retrospective analysis.疑似巨细胞动脉炎的颞动脉活检:回顾性分析。
Rheumatol Int. 2021 Oct;41(10):1803-1810. doi: 10.1007/s00296-020-04738-7. Epub 2020 Nov 6.

引用本文的文献

1
Headache as the most common manifestation of giant cell arteritis?: a systematic review with meta-analysis.头痛是巨细胞动脉炎最常见的表现吗?一项荟萃分析的系统评价
Rheumatol Int. 2025 Feb 11;45(3):47. doi: 10.1007/s00296-025-05803-9.
2
Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria.巨细胞动脉炎的血管炎分布及临床特征:一项采用2022年美国风湿病学会/欧洲抗风湿病联盟新分类标准的回顾性研究
Front Med (Lausanne). 2023 Nov 13;10:1286601. doi: 10.3389/fmed.2023.1286601. eCollection 2023.
3
Current developments in the diagnosis and treatment of giant cell arteritis.

本文引用的文献

1
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.巨细胞动脉炎和风湿性多肌痛的发病率和患病率:系统文献回顾。
Semin Arthritis Rheum. 2020 Oct;50(5):1040-1048. doi: 10.1016/j.semarthrit.2020.07.005. Epub 2020 Jul 14.
2
Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis.颞动脉活检对巨细胞动脉炎诊断的敏感性:系统文献回顾和荟萃分析。
Rheumatology (Oxford). 2020 May 1;59(5):1011-1020. doi: 10.1093/rheumatology/kez385.
3
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
巨细胞动脉炎诊断与治疗的当前进展
Front Med (Lausanne). 2022 Dec 13;9:1066503. doi: 10.3389/fmed.2022.1066503. eCollection 2022.
4
Global epidemiology of vasculitis.血管炎的全球流行病学。
Nat Rev Rheumatol. 2022 Jan;18(1):22-34. doi: 10.1038/s41584-021-00718-8. Epub 2021 Dec 1.
5
Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort.在一个北美的基于人群的队列中,GCA 在 70 年中的发病率、生存率和诊断趋势。
Semin Arthritis Rheum. 2021 Dec;51(6):1193-1199. doi: 10.1016/j.semarthrit.2021.09.006. Epub 2021 Sep 27.
2018 年版 EULAR 大血管血管炎管理建议更新。
Ann Rheum Dis. 2020 Jan;79(1):19-30. doi: 10.1136/annrheumdis-2019-215672. Epub 2019 Jul 3.
4
The different clinical patterns of giant cell arteritis.巨细胞动脉炎的不同临床类型。
Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):57-60. Epub 2019 May 21.
5
Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis.瑞典风湿病学会 2018 年巨细胞动脉炎的调查、治疗和随访指南。
Scand J Rheumatol. 2019 Jul;48(4):259-265. doi: 10.1080/03009742.2019.1571223. Epub 2019 Mar 6.
6
Evolving concepts in classification of systemic vasculitis: where are we and what is the way forward?系统性血管炎分类的演变概念:我们现在处于什么位置以及未来的方向是什么?
Int J Rheum Dis. 2019 Jan;22 Suppl 1:21-27. doi: 10.1111/1756-185X.13304. Epub 2018 Apr 29.
7
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.巨细胞动脉炎和风湿性多肌痛的谱系:重新审视疾病概念
Rheumatology (Oxford). 2017 Apr 1;56(4):506-515. doi: 10.1093/rheumatology/kew273.
8
Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease pattern.无颅部表现的巨细胞动脉炎:一种独特疾病模式的工作诊断
Medicine (Baltimore). 2016 Jun;95(26):e3818. doi: 10.1097/MD.0000000000003818.
9
ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).ACR/EULAR 认可的研究旨在制定血管炎的诊断和分类标准(DCVAS)。
Clin Exp Nephrol. 2013 Oct;17(5):619-621. doi: 10.1007/s10157-013-0854-0. Epub 2013 Aug 31.
10
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.2012年修订的国际 Chapel Hill 共识会议血管炎命名法
Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715.